Article

Clinical outcomes and mutation analysis of carbon ion radiotherapy for bladder urothelial carcinoma

2025-07-10

Abstract excerpt

<title>Abstract</title> <p>Carbon–ion radiotherapy (CIRT) improves the survival outcomes in patients with tumor recurrence or metastasis. However, there is little data to support the clinical efficacy of CIRT for bladder cancer. Ten patients underwent CIRT between November 2020 and July 2023 (ChiCTR2100043607). A comprehensive evaluation of the tumor control and toxicity of CIRT was performed, and the clinical ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f576c64-4a20-556a-bc90-3cd682ae40ae
DOI: 10.21203/rs.3.rs-6725919/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical outcomes and mutation analysis of carbon ion radiotherapy for bladder urothelial carcinomaDOI 10.21203/rs.3.rs-6725919/v1Read

Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/RepairSemantic proximity Read

Trimodal Therapy for T3 Muscle-Invasive Bladder Cancer：a retrospective case series studySemantic proximity Read

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read

A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report.Semantic proximity Read

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experienceSemantic proximity Read

XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.Semantic proximity Read

Genetic determinants for chemo- and radiotherapy resistance in bladder cancerSemantic proximity Read

EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cellsSemantic proximity Read

Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancerSemantic proximity Read

Research on Deep Learning-Based Relative Biological Effectiveness Prediction MethodSemantic proximity Read

Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective studySemantic proximity Read

Innovative In Vitro-In Silico Platform for Dose-Response Modeling in Canine Bladder Cancer: A 3D Organoid- and Mathematics-Based ApproachSemantic proximity Read